Exiqon A/S has announced the launch of its miRCURY™ Exosome Isolation kits for exosome isolation from various biofluids and cell media.
Over the past few years the body of scientific literature has documented the biological importance of exosomes. Exosomes play a key role in cell to cell communication, cell migration, cell differentiation etc. Exosomes contain protein and RNA and may be a preferred target for identification of new biomarkers.
However, the isolation of exosomes is challenged by the lack of reproducibility, lack of specificity and tedious work processes. Exiqon’s new miRCURY™ Exosome Isolation Kits address these challenges.
The miRCURY™ Exosome Isolation Kits ensure very high recovery of exosomes in less than two hours and is based on non-toxic reagents. By the use of miRCURY™ Exosome Isolation Kits, exosomes may be isolated from divers sources such as serum, plasma, urine, CSF and cell culture media.
“The miRCURY™ Exosome Isolation Kits consolidate Exiqon as the leading provider of products for analysis of biofluids. With many auxiliary and integrated products Exiqon are able to provide solutions for any RNA biomarker study in biofluids” says Henrik M. Pfundheller, SVP, Sales and Marketing.
The miRCURY™ Exosome Isolation Kits are optimized for use with the miRCURY™ RNA Isolation Kits and the miRCURY LNA™ Universal RT microRNA PCR platform. Exiqon’s PCR offering now includes two new Exosome miRCURY LNA™ Universal RT microRNA qPCR Focus Panels.
The focus Panels contain LNA™ enhanced primer sets targeting microRNAs typically found in exosomes from urine and CSF. The primer sets have been thoroughly selected from a combination of literature mining and Exiqon’s internal diagnostic microRNA programs.